Article Text
Treatment
Benefits of early intensive glucose control in preventing diabetes-related complications were sustained for up to 10 years
Statistics from Altmetric.com
Footnotes
Source of funding: UK Medical Research Council; UK Department of Health; Diabetes UK; British Heart Foundation; UK National Institute for Health; Bristol-Myers Squibb; GlaxoSmithKline; Mereck Serono; Norvartis; Novo Nordisk; Pfizer.